Interferon regulatory factor 2 binding protein 2b regulates neutrophil versus macrophage fate during zebrafish

Luxiang Wang1, Shuo Gao1, Haihong Wang1

  • 1CNRS-LIA Hematology and Cancer, Sino-French Research Center for Life Sciences and Genomics, State Key Laboratory of Medical Genomics, Rui-Jin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.

Haematologica
|May 25, 2019
PubMed

Insights

Interferon regulatory factor 2 binding protein 2b (Irf2bp2b) is crucial for balanced neutrophil and macrophage development. Its depletion biases progenitor cell fate toward macrophages, highlighting its role in myeloid lineage determination.

Area of Science:

  • Developmental Biology
  • Hematopoiesis
  • Cell Fate Determination

Background:

  • Neutrophil and macrophage production is vital for immune function.
  • Key regulators like C/EBPα and PU.1 govern myeloid progenitor cell fate.
  • Additional regulators are needed to understand lineage commitment.

Purpose of the Study:

  • To identify novel regulators of neutrophil-macrophage progenitor cell fate.
  • To characterize the role of interferon regulatory factor 2 binding protein 2b (Irf2bp2b) in myeloid development.

Main Methods:

  • Investigated the function of Irf2bp2b in zebrafish embryonic myelopoiesis.
  • Performed mechanistic studies to elucidate Irf2bp2b's regulatory pathway.
  • Assessed the impact of Irf2bp2b depletion on progenitor cell fate.

Main Results:

  • Depletion of Irf2bp2b caused a bias towards macrophages, reducing neutrophil generation.
  • Irf2bp2b acts downstream of C/EBPα and represses PU.1 expression.
  • SUMOylation is essential for Irf2bp2b's transcriptional repressive function.

Conclusions:

  • Irf2bp2b is a novel determinant controlling neutrophil-macrophage progenitor cell fate.
  • Irf2bp2b integrates upstream signals to ensure balanced myeloid lineage commitment.
  • Understanding Irf2bp2b function is key to controlling myeloid cell production.

Related Concept Videos

Cooperative Binding of Transcription Regulators02:13

Cooperative Binding of Transcription Regulators

Transcriptional regulators bind to specific cis-regulatory sequences in the DNA to regulate gene transcription. These cis-regulatory sequences are very short, usually less than ten nucleotide pairs in length. The short length means that there is a high probability of the exact same sequence randomly occurring throughout the genome.  Since regulators can also bind to groups of similar sequences, this further increases the chances of random binding. Transcriptional regulators form...
7.2K
Factors Affecting Protein-Drug Binding: Protein-Related Factors01:20

Factors Affecting Protein-Drug Binding: Protein-Related Factors

Drug binding to proteins is a key aspect of pharmacokinetics and can influence a drug's distribution, absorption, and elimination in the body. Several factors, including the drug's physiochemical properties, protein concentration, disease states, and the number of binding sites on the protein, influence this process.
The physicochemical properties of a drug play a significant role in its ability to bind to proteins. Lipophilic drugs, which dissolve in fats, oils, and lipids, can be...
535
Factors Affecting Protein-Drug Binding: Drug-Related Factors01:18

Factors Affecting Protein-Drug Binding: Drug-Related Factors

Drug binding to proteins is a complex phenomenon influenced by various drug-related factors, each playing a significant role in the interaction between drugs and proteins within the body.
One crucial factor in drug-protein binding is the drug's lipophilicity or its affinity for fat. More lipophilic drugs tend to have higher binding extents. For example, highly lipophilic drugs like cloxacillin exhibit substantial protein binding, with as much as 95% of the drug binding to proteins. In...
462
Factors Affecting Protein-Drug Binding: Patient-Related Factors01:29

Factors Affecting Protein-Drug Binding: Patient-Related Factors

Protein-drug binding, a pivotal aspect of pharmacokinetics, is subject to considerable variability influenced by an array of patient-related factors. The intricate interplay of age, individual differences, and pathological conditions significantly impact the binding dynamics and subsequent pharmacological effects.
Age stands as a key determinant in protein-drug binding. Neonates, characterized by low albumin content, experience heightened concentrations of unbound drugs such as phenytoin and...
312
Cis-regulatory Sequences02:02

Cis-regulatory Sequences

Cis-regulatory sequences are short fragments of non-coding DNA that are present on the same chromosomes as the genes that they regulate. These fragments serve as binding sites for transcriptional regulators, proteins that are responsible for controlling gene transcription and differential gene expression across cell types in eukaryotes. Cis-regulatory sequences can be close to the gene of interest or thousands of bases away in the DNA sequence; however, those sequences that are further away are...
11.6K
Master Transcription Regulators02:23

Master Transcription Regulators

Master transcription regulators are regulatory proteins that are predominantly responsible for regulating the expression of multiple genes. Often these genes work in concert to drive a  complex process. Activation of a master transcription regulator can lead to a cascade of transcriptional activation necessary for that outcome. These regulators can directly bind to the regulatory sequences of the various genes involved, or they can indirectly regulate transcription by binding to regulatory...
7.7K